Qaelon Medical

Qaelon Medical has developed the first and only platform that integrates real-time, digital leak detection with smart insufflation for minimally invasive surgery. Its technology detects sub-millimeter leaks by analyzing gas composition changes with 100% accuracy in preclinical testing, addressing a major cause of post-operative complications in colorectal and other surgeries. Founded in 2017 and based in Lyon, France, Qaelon is positioning its platform as a new standard of care across robotic, laparoscopic, and endoluminal procedures. The company is pre-revenue and focused on clinical validation and integration partnerships to drive adoption.

Integrated hardware-software platform combining a constant-flow insufflator with real-time gas composition (O2/CO2) sensors and proprietary algorithms to digitally detect surgical anastomotic leaks.

Qaelon appears to be first-to-market with a dedicated, real-time digital leak detection platform. Current competition is the analog standard of care (air leak test). Potential future competitors include large insufflation or robotic surgery companies (e.g., Stryker, Intuitive Surgical) that could develop similar integrated features.